Skip to content

Compare medicines

Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.

Attribute
In shortFast-acting mealtime insulin.Once-daily long-acting background insulin.
Body systemDiabetes & WeightDiabetes & Weight
Drug classInsulinsInsulins
SupplyPrescription onlyPrescription onlyWHO essential medicine
Main usesType 1 diabetes (mealtime and pumps), Type 2 diabetes needing mealtime insulin, Diabetic ketoacidosis (IV regimens use soluble insulin)Type 1 diabetes (basal), Type 2 diabetes
How it worksWorks fast to cover the sugar from a meal.Releases slowly from under the skin to keep blood sugar steady all day and night.
Starts working10–20 minutes; peak 1–3 hours1–2 hours, no peak
Half-lifeDuration 3–5 hoursDuration about 24 hours
Typical adult doseIndividual — given 0–15 minutes before meals, adjusted to carbohydrate intake.Individual — commonly started at 10 units (or 0.1–0.2 units/kg) once a day and adjusted to fasting glucose.
FormsPen injection, Vial, Pump cartridgePen injection, Vial, Cartridge
Common side effectsLow blood sugar, Injection-site reactionsLow blood sugar, Weight gain, Injection-site lumps
Serious side effectsSevere hypoglycaemia, Low potassiumSevere hypoglycaemia, Low potassium (rare)
Don't take if——
Alcohol——
PregnancyGenerally considered safeUsed routinely in pregnancy.Generally considered safeInsulin is the mainstay of diabetes treatment in pregnancy.
Breastfeeding——
In use since19992000
Brand namesUnited States: NovoLog, FiaspUnited Kingdom: NovoRapid, FiaspIndia: NovoRapidUnited States: Lantus, Toujeo, Basaglar, SemgleeUnited Kingdom: Lantus, Toujeo, AbasaglarIndia: Lantus, Basalog, Glaritus
Legal status——
ATC codeA10AB05A10AE04

Taken together

  • MinorInsulin aspart + Insulin glargine: More risk of low blood sugar

    Both medicines lower blood sugar; combinations are common but hypos become more likely.

Open in the interaction checker